首页> 外文期刊>Journal of Applied Polymer Science >Diet supplement based on radiation-modified chitosan and radiation-synthesized polyvinylpyrrolidone microgels: Influence on the liver weight in rats fed a fat- and cholesterol-rich diet
【24h】

Diet supplement based on radiation-modified chitosan and radiation-synthesized polyvinylpyrrolidone microgels: Influence on the liver weight in rats fed a fat- and cholesterol-rich diet

机译:基于辐射改性的壳聚糖和辐射合成的聚乙烯吡咯烷酮微凝胶的膳食补充剂:对富含脂肪和胆固醇的饮食的大鼠肝脏重量的影响

获取原文
获取原文并翻译 | 示例
           

摘要

A polymer-based preparation (a chitosan-microgel preparation called CHM), intended for use as a diet supplement reducing fat and cholesterol absorption from the digestive tract, was obtained by the combination of chitosan of a reduced molecular weight with a polyvinylpyrrolidone microgel in a I : I (w/w) ratio. Both components were obtained with ionizing radiation (controlled degradation of chitosan in the solid state and crosslinking polymerization of neat vinylpyrrolidone). The chitosan component was shown in previous in vitro studies to exhibit a high fat-binding capacity, whereas the microgels, able to swell to about 40 times their original volume, were intended to serve as stomach-filling agents. The influence of the CHM preparation on the body mass, the weight of the liver and other principal organs, and the serum levels of triglycerides and cholesterol was examined in rats fed a fat- and cholesterol-rich diet (FChD). It was found that the preparation administered as a diet additive at 4% CHM (2% chitosan) in rats effectively prevented body mass gain, fat accumulation in the liver, and liver enlargement, which otherwise developed in the animals fed FChD only, whereas the weight of the other main organs (heart, liver, kidney, spleen, testicles, and lungs) remained unaltered. CHM was also capable of exerting this effect when administered to animals already in an atherosclerotic, overweight condition. No adverse effects were observed during the 10 weeks of feeding the animals the CHM-containing diet. (C) 2007 Wiley Periodicals, Inc.
机译:通过降低分子量的壳聚糖与聚乙烯吡咯烷酮微凝胶的组合,获得了一种聚合物基制剂(称为CHM的壳聚糖微凝胶制剂),旨在用作饮食添加剂以减少脂肪和胆固醇从消化道的吸收。 I:I(w / w)比率。两种组分均通过电离辐射(固态下壳聚糖的受控降解和纯乙烯基吡咯烷酮的交联聚合)获得。壳聚糖成分在先前的体外研究中显示具有较高的脂肪结合能力,而能够溶胀至其原始体积约40倍的微凝胶则打算用作胃填充剂。在饲喂富含脂肪和胆固醇的饮食(FChD)的大鼠中,检查了CHM制剂对体重,肝脏和其他主要器官的重量以及血清甘油三酸酯和胆固醇水平的影响。发现以4%CHM(2%壳聚糖)为饮食添加剂的大鼠制剂可有效防止体重增加,肝脏中脂肪堆积和肝脏肿大,否则仅在饲喂FChD的动物体内会出现这种情况,而其他主要器官(心脏,肝脏,肾脏,脾脏,睾丸和肺脏)的重量保持不变。当对已经处于动脉粥样硬化,超重状态的动物给药时,CHM也能够发挥这种作用。在给动物喂食含CHM饮食的10周内未观察到不良影响。 (C)2007 Wiley期刊公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号